Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Stomach Neoplasms 1 Resectable Pancreatic Cancer 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastroesophageal Adenocarcinoma 1 Colorectal Cancer Metastatic 1 Ampullary Adenocarcinoma 1

Interventions

Oxaliplatin 35 Fluorouracil 26 Capecitabine 20 pembrolizumab 19 Paclitaxel 18 Leucovorin 16 S 1 (combination) 13 Docetaxel 13 tislelizumab 11 Nivolumab 10 sintilimab 9 Trastuzumab 9 trastuzumab deruxtecan 8 Irinotecan 8 Cisplatin 7 Bevacizumab 7 fludarabine 6 XELOX 6 Surgical Procedures, Operative 6 Specimen Handling 6 Radiotherapy 6 Drug Therapy 6 Cyclophosphamide 6 Biopsy 6 lenvatinib 5 disitamab vedotin 5 apatinib 5 aldesleukin 5 Magnetic Resonance Spectroscopy 5 Injections 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03825861 2020-11-10

FOLFIRINOX

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡